
Nephrologist

No OPD information available
Hyperaldosteronism
Adrenal Gland Adenoma
Hypertension
Adrenal Cancer
Autosomal Dominant Polycystic Kidney Disease
Chronic Kidney Disease
Cushing's syndrome
End-Stage Renal Disease (ESRD)
Familial Hyperaldosteronism
Jaundice
Polycystic Kidney Disease
Primary Hyperoxaluria
Primary Hyperoxaluria Type 1
Secondary Immunodeficiency (SID)
Vitamin D Deficiency
Martin J. Wolley is a male doctor who helps people with different health problems like Hyperaldosteronism, Adrenal Gland Adenoma, Hypertension, and more. He also treats conditions like Cushing's syndrome, Jaundice, and Vitamin D Deficiency.
Dr. Wolley is very skilled at what he does and uses special treatments to help his patients feel better. He is good at talking to his patients and making them feel comfortable. Patients trust him because he listens to them and explains things in a way they can understand.
Dr. Wolley stays updated with the latest medical knowledge so he can provide the best care for his patients. He works well with other doctors and medical professionals to make sure his patients get the right treatment.
One of Dr. Wolley's studies, "Plasma Potassium Negatively Correlates With Sodium Chloride Cotransporter Abundance and Phosphorylation in Urinary Extracellular Vesicles From Patients With Chronic Kidney Disease," was published in a medical journal. He is also involved in a clinical trial called "The INCremental Dialysis to Improve Health Outcomes in People Starting Haemodialysis (INCH-HD) Study."
Dr. Wolley's work has made a positive impact on many patients' lives. He helps them feel better and live healthier lives. Patients appreciate his care and expertise in treating their health conditions.
Overall, Dr. Wolley is a dedicated and knowledgeable doctor who works hard to help his patients and improve their health. His commitment to staying informed about the latest medical research and his compassionate approach to patient care make him a trusted and respected healthcare provider.
Enrollment Status: Recruiting
Published: April 18, 2024
Intervention Type: Other
Study Drug:
Study Phase: Not Applicable
